BackGenMark Diagnostics Overview

GenMark Diagnostics Current Cash

Track GenMark Diagnostics's current cash ($41M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$40.57M
↓ 8.54% YoYΔ $-3.79M vs prior year quarter

Peer trimmed avg / median

Loading

GenMark Diagnostics Current Cash History

Loading

GenMark Diagnostics vs. peers: Current Cash Comparison

Loading

GenMark Diagnostics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GenMark Diagnostics (GNMK) FAQ

GenMark Diagnostics (GNMK) currently reports a current cash of $41M as of December 2020. That compares with $44M in the prior-year period — down 8.5% year over year. Use the charts on this page to explore GenMark Diagnostics's current cash history and peer comparisons.

GenMark Diagnostics's current cash decreased from $44M to $41M — a 8.5% year-over-year decrease (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GenMark Diagnostics reported $41M in current cash as of December 2020. That compares with $44M in the prior-year period — down 8.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $41M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GenMark Diagnostics, and consider following GNMK for alerts when major investors trade the stock.

GenMark Diagnostics is classified in the Healthcare sector. On current cash, it currently shows $41M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GNMK with unrelated industries.